Becton, Dickinson and Co. | BDX - Assets


Becton, Dickinson and Co. reported $50.73B in Assets for its fiscal quarter ending in June of 2026.





Assets Change Date
Abbott USD 110.43B 23.72B Mar/2026
Agilent USD 13.07B 252M Mar/2026
Align Technology USD 6.42B 103.41M Jun/2026
AngioDynamics USD 269.68M 4.04M Sep/2025
Baxter International USD 19.79B 55M Jun/2026
Becton, Dickinson and Co. USD 50.73B 101M Jun/2026
Bio-Rad Laboratories USD 10.25B 462M Jun/2026
Boston Scientific USD 45.22B 865M Jun/2026
Cooper Companies USD 12.48B 58.1M Mar/2026
Danaher USD 92.37B 8.82B Jun/2026
Dentsply International USD 5.2B 25M Jun/2026
Dexcom USD 6.46B 178M Jun/2026
Edwards Lifesciences USD 13.87B 545.9M Jun/2026
Globus Medical USD 5.49B 48.7M Jun/2026
Insulet USD 3.17B 177.9M Jun/2026
Integra LifeSciences USD 3.56B 14.24M Jun/2026
Intuitive Surgical USD 20.88B 765.6M Jun/2026
J&J USD 201.06B 167M Jun/2026
Medtronic USD 93.03B 1.54B Mar/2026
Solventum Corp USD 14.24B 146M Jun/2026
Stryker USD 47.93B 1.64B Jun/2026
Tandem Diabetes Care USD 1.15B 808K Jun/2026
Teleflex USD 6.79B 3.78M Jun/2026
Terumo JPY 2.37T 61.86B Jun/2026
Thermo Fisher Scientific USD 113.17B 107M Jun/2026
Zimmer Biomet Holdings USD 22.8B 76.2M Jun/2026